Medivir Future Growth

Medivir is forecast to grow earnings and revenue by 37.9% and 58.8% per annum respectively while EPS is expected to grow by 38.3% per annum.

37.9%

Earnings growth rate

38.3%

EPS growth rate

No updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:MVIRS - Analysts future estimates and past financials data (SEK Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	10	-163	-204	-125	4
12/31/2025	52	-92	-170	-37	4
12/31/2024	32	-75	-45	-71	3
3/31/2024	8	-97	-79	-79	N/A
12/31/2023	8	-89	-60	-60	N/A
9/30/2023	6	-87	-80	-80	N/A
6/30/2023	6	-78	-79	-78	N/A
3/31/2023	4	-75	-78	-78	N/A
12/31/2022	4	-89	-102	-102	N/A
9/30/2022	23	-95	-83	-83	N/A
6/30/2022	23	-94	-83	-83	N/A
3/31/2022	23	-88	-87	-87	N/A
12/31/2021	32	-63	-49	-49	N/A
9/30/2021	3	-50	-47	-44	N/A
6/30/2021	19	-32	-44	-41	N/A
3/31/2021	23	-27	-46	-43	N/A
12/31/2020	20	-43	-61	-58	N/A
9/30/2020	30	-64	-81	-80	N/A
6/30/2020	14	-91	-98	-96	N/A
3/31/2020	14	-91	-110	-109	N/A
12/31/2019	9	-123	-150	-148	N/A
9/30/2019	21	-206	-196	-196	N/A
6/30/2019	23	-254	-244	-241	N/A
3/31/2019	21	-333	-293	-288	N/A
12/31/2018	24	-350	-325	-319	N/A
9/30/2018	15	-339	-345	-337	N/A
6/30/2018	17	-348	-328	-322	N/A
3/31/2018	23	-348	-329	-322	N/A
12/31/2017	37	-360	N/A	-358	N/A
9/30/2017	42	-379	N/A	-341	N/A
6/30/2017	63	-353	N/A	-315	N/A
3/31/2017	90	-320	N/A	-270	N/A
12/31/2016	93	-295	N/A	-182	N/A
9/30/2016	-16	-262	N/A	-108	N/A
6/30/2016	70	-218	N/A	4	N/A
3/31/2016	279	-95	N/A	106	N/A
12/31/2015	474	32	N/A	347	N/A
9/30/2015	950	268	N/A	855	N/A
6/30/2015	1,456	652	N/A	1,253	N/A
3/31/2015	1,775	916	N/A	1,277	N/A
12/31/2014	1,767	1,133	N/A	1,014	N/A
9/30/2014	1,537	1,005	N/A	580	N/A
6/30/2014	1,000	620	N/A	101	N/A
3/31/2014	476	229	N/A	4	N/A
12/31/2013	446	16	N/A	43	N/A
9/30/2013	348	-74	N/A	-82	N/A
6/30/2013	304	-119	N/A	-116	N/A

Earnings vs Savings Rate: MVIRS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MVIRS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MVIRS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MVIRS's revenue (58.8% per year) is forecast to grow faster than the UK market (3.7% per year).

High Growth Revenue: MVIRS's revenue (58.8% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if MVIRS's Return on Equity is forecast to be high in 3 years time